Synergy between transcription factors DBP and C/EBP compensates for a haemophilia B Leyden factor IX mutation
Open Access
- 1 February 1993
- journal article
- research article
- Published by Springer Nature in Nature Genetics
- Vol. 3 (2) , 175-179
- https://doi.org/10.1038/ng0293-175
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Recovery from Hemophilia B Leyden: An Androgen-Responsive Element in the Factor IX PromoterScience, 1992
- An A to T transversion at position −5 of the Factor IX promoter results in hemophilia BGenomics, 1992
- Haemophilia B: database of point mutations and short additions and deletions--second editionNucleic Acids Research, 1991
- Haemophilia B Leyden arising de novo by point mutation in the putative factor IX promoter regionBritish Journal of Haematology, 1991
- A less severe form of Haemophilia B LeydenNucleic Acids Research, 1990
- Structural and functional basis of the developmental regulation of human coagulation factor IX gene: factor IX Leyden.Proceedings of the National Academy of Sciences, 1990
- Disruption of a C/EBP binding site in the factor IX promoter is associated with haemophilia BNature, 1990
- Two novel point mutations correlate with an altered developmental expression of blood coagulation factor IX (hemophilia B Leyden phenotype)Blood, 1989
- The putative factor IX gene promoter in hemophilia B LeydenBlood, 1988
- Hemophilia B LeydenNew England Journal of Medicine, 1982